HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ribavarin should be tested in clinical trials in combination with other antiviral agents for severe acute respiratory syndrome.

AuthorsChung-Ming Chu, Kin-Sang Chan
JournalChest (Chest) Vol. 128 Issue 6 Pg. 4050 (Dec 2005) ISSN: 0012-3692 [Print] United States
PMID16354884 (Publication Type: Comment, Comparative Study, Letter)
Chemical References
  • Antiviral Agents
  • Ribavirin
Topics
  • Antiviral Agents (adverse effects, therapeutic use)
  • Cause of Death
  • Clinical Trials as Topic
  • Drug Therapy, Combination
  • Humans
  • Needs Assessment
  • Ribavirin (adverse effects, therapeutic use)
  • Risk Assessment
  • Severe Acute Respiratory Syndrome (diagnosis, drug therapy, mortality)
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: